​Biotech Connection Singapore and Gunderson Dettmer invite you to join us for an insightful presentation, fireside chat, and an opportunity to connect with other biotech founders.

​The workshop will focus on key fundraising considerations for early-stage startups. The panel will discuss industry trends, challenges, and best practices in biotech fundraising.

​Program

​4:30pm-5:00pm: Registration
5:00pm-5:05pm: Introduction
5:05pm-5:30pm: Presentation - Venture Financing Basics
5:30pm-6:45pm: Fireside Chat
7:00pm-8:00pm: Networking (refreshments will be provided)

​About our Speakers:

​

​[Moderator] Jonathan Pentzien, Singapore Managing Partner at Gunderson Dettmer
Jon is the managing and founding partner of Gunderson Dettmer’s Singapore office. Previously based in the firm’s New York office, Jon has over 15 years of experience advising global emerging growth technology companies throughout their lifecycle and acting for venture and growth equity investors on some of the largest financing rounds and M&A transactions in India and Southeast Asia. Jon is recognized as a Leading Individual for Start-Up and Venture Capital by The Legal 500 Asia-Pacific since 2023, a Band 1 Leading Individual for Startups & Emerging Companies by Chambers Asia-Pacific since 2021, and named to India Business Law Journal’s A-List since 2020.

​

​Dr. Wen Qi Ho, Therapeutic Lead at ClavystBio
Wen Qi is the Therapeutic Lead at ClavystBio, focusing on investing in and building global healthcare companies from Singapore. Previously CEO at Lightstone Ventures, she played a major role in establishing the firm’s presence in Singapore and was actively involved in venture-building companies like Medisix Therapeutics and Allay Therapeutics. Wen Qi advocates for early career researcher participating in biotech entrepreneurship, and serves on advisory and grant review panels in Singapore. She also serves on boards of ClavystBio’s portfolio companies. Wen Qi holds a PhD in Immunology from Stanford University, and BSc in Molecular and Cellular Biology at Johns Hopkins University.

​

​Ritika Khetawat, Founder at MissionBridge
RRitika is the founder of MissionBridge, a consulting firm specialising in early-stage capital raising for innovative start-ups in the biotech and medtech space. Ritika has raised over US$2 Billion through her work spanning investment banking and start-up fundraising across South East Asia and India. She successfully managed large-scale M&A transactions and fundraising efforts, driving significant impact for her clients at both Goldman Sachs and Morgan Stanley, in the early years of her career. In her most recent role as the Head of Corporate Development for a growth-stage biotech firm in Singapore, Ritika played a key role in securing over US$300 million in funding from leading investors and sovereign wealth funds in the region.

​This event is jointly hosted by the Biotech Connection Singapore and Gunderson Dettmer.

​Biotech Connection Singapore is a non-profit independent ecosystem builder that aims to foster interactions between different stakeholders in the biomedical and healthcare space, as well as promote bio-entrepreneurship in Singapore. Established in October 2014, BCS is the Singapore chapter of a global network, with chapters in biotech hubs such as San Francisco (BCBA) and Los Angeles (BCLA).

​Gunderson Dettmer – with over 400 lawyers across 11 offices in key venture markets worldwide – is the preeminent international law firm with an exclusive focus on the innovation economy. Headquartered in Silicon Valley, our Singapore office serves as the hub for our India and Southeast Asia practice, is consistently recognized as the "most active venture capital law firm" in India and Southeast Asia by Pitchbook's Global League Tables, and top-ranked in The Legal 500 Asia-Pacific, Chambers Asia-Pacific and the India Business Law Journal.